-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Betta Pharmaceutical (300558.SZ) issued an announcement. Recently, the BPI-572270 capsule clinical trial application declared by Hangzhou Jingyao Biotechnology Co., Ltd., a wholly-owned subsidiary of the company, was approved by the US Food and Drug Administration (“US FDA”). This drug is intended for advanced solid tumors.

Zhitongcaijing·10/07/2026 11:49:09
Listen to the news
Zhitong Finance App News, Betta Pharmaceutical (300558.SZ) issued an announcement. Recently, the BPI-572270 capsule clinical trial application declared by Hangzhou Jingyao Biotechnology Co., Ltd., a wholly-owned subsidiary of the company, was approved by the US Food and Drug Administration (“US FDA”). This drug is intended for advanced solid tumors.